Abstract
Despite the availability of HPV prophylactic vaccines, uptake has been suboptimal in the US. In the state of Hawaii, HPV vaccine coverage has decreased among females and remains low among males aged 13–17. The reasons for low uptake are unknown and may indicate the existence of critical barriers to HPV vaccination. The purpose of this investigation was to identify policy, system and environmental barriers and promoters of pediatric HPV vaccination in Hawaii. An online 86-item survey addressing knowledge, attitudes, beliefs, practices, and barriers to HPV vaccination was distributed to practicing physicians in Hawaii specializing in Pediatrics, Family Medicine, and Obstetrics-Gynecology. Survey responses were received from a total of 120 physicians. Private practice physicians reported more concerns with vaccine ordering and stocking costs (p < 0.0001), reimbursement levels (p < 0.0001), and insurance coverage (p < 0.0001) compared to physicians in large group practices. Eighty-three percent of providers cited lack of parent knowledge and understanding of HPV infection as a barrier. Over half of physicians (58 %) reported that completion of the 3-dose schedule was a barrier. Most physicians did not use tracking or reminder systems to ensure dose completion. A majority (58 %) of providers cited the lack of school-based vaccination requirements as a barrier. Uptake of HPV vaccination in Hawaii may be impeded by physician perception of parent knowledge and attitudes. Cost-related system barriers are particular barriers among those in private practice. Completion of the 3-dose schedule also remains a challenge.
Similar content being viewed by others
References
Reagan-Steiner, S., Yankey, D., Jeyarajah, J., Elam-Evans, L. D., Singleton, J. A., Curtis, C. R., et al. (2015). National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years–United States, 2014. Morbidity and Mortality Weekly Report, 64(29), 784–792.
Forman, D., de Martel, C., Lacey, C. J., Soerjomataram, I., Lortet-Tieulent, J., Bruni, L., et al. (2012). Global burden of human papillomavirus and related diseases. Vaccine, 30, F12–F23.
Satterwhite, C. L., Torrone, E., Meites, E., Dunne, E. F., Mahajan, R., Ocfemia, M. C. B., et al. (2013). Sexually transmitted infections among US women and men: Prevalence and incidence estimates, 2008. Sexually Transmitted Diseases, 40(3), 187–193.
Cardoso, J., & Calonje, E. (2011). Cutaneous manifestations of human papillomaviruses: a review. Acta dermatovenerologica Alpina Pannonica et Adriatica, 20(3), 145–154.
Centers for Disease Control and Prevention (CDC). (2010). FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report, 59(20), 626.
Centers for Disease Control and Prevention (CDC). (2011). Recommendations on the use of quadrivalent human papillomavirus vaccine in males–Advisory Committee on Immunization Practices (ACIP), 2011. Morbidity and Mortality Weekly Report, 60(50), 1705.
Petrosky, E., Bocchini, J., Hariri, S., Chesson, H., Curtis, C. R., Saraiya, M., et al. (2015). Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. Morbidity and Mortality Weekly Report, 64(11), 300–304.
Lu, B., Kumar, A., Castellsagué, X., & Giuliano, A. R. (2011). Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review and meta-analysis. BMC Infectious Diseases, 11(1), 1.
Centers for Disease Control and Prevention CDC. (2013). Human papillomavirus vaccination coverage among adolescent girls, 2007–2012, and post-licensure vaccine safety monitoring, 2006–2013-United States. Morbidity and Mortality Weekly Report, 62(29), 591.
Stokley, S., Jeyarajah, J., Yankey, D., Cano, M., Gee, J., Roark, J., et al. (2014). Human papillomavirus vaccination coverage among adolescents, 2007–2013, and post-licensure vaccine safety monitoring, 2006–2014–United States. Morbidity and Mortality Weekly Report, 63(29), 620–624.
Kash, N., Lee, M. A., Kollipara, R., Downing, C., Guidry, J., & Tyring, S. K. (2015). Safety and efficacy data on vaccines and immunization to human papillomavirus. Journal of Clinical Medicine, 4(4), 614–633.
US Department of Health and Human Services. (2011). Healthy people 2020. Washington, DC: US Department of Health and Human Services; 2010.
National Cancer Institute (US) (2014). Accelerating HPV vaccine uptake: urgency for action to prevent cancer. A report to the President of the United States from the President’s Cancer Panel. Bethesda, MD: National Cancer Institute.
Elam-Evans, L. D., Yankey, D., Singleton, J. A., Kolasa, M., & Centers for Disease Control and Prevention. (2014). National, state, and selected local area vaccination coverage among children aged 19–35 months—United States, 2013. Morbidity and Mortality Weekly Report, 63(34), 741–748.
Cates, J. R., Shafer, A., Carpentier, F. D., Reiter, P. L., Brewer, N. T., McRee, A., et al. (2010). How parents hear about human papillomavirus vaccine: Implications for uptake. Journal of Adolescent Health, 47(3), 305–308.
Gargano, L. M., Herbert, N. L., Painter, J. E., Sales, J. M., Morfaw, C., Rask, K., et al. (2013). Impact of a physician recommendation and parental immunization attitudes on receipt or intention to receive adolescent vaccines. Human vaccines and immunotherapeutics, 9(12), 2627–2633.
Allen, J. D., Othus, M. K., Shelton, R. C., Li, Y., Norman, N., Tom, L., et al. (2010). Parental decision making about the HPV vaccine. Cancer Epidemiology, Biomarkers and Prevention, 19(9), 2187–2198.
Brewer, N. T., Gottlieb, S. L., Reiter, P. L., McRee, A., Liddon, N., Markowitz, L., et al. (2011). Longitudinal predictors of HPV vaccine initiation among adolescent girls in a high-risk geographic area. Sexually Transmitted Diseases, 38(3), 197.
Soon, R., Cruz, M. R. I. D., Tsark, J. U., Chen, J. J., & Braun, K. L. (2015). A Survey of physicians’ attitudes and practices about the human papillomavirus (HPV) vaccine in Hawai ‘i. Hawai’i Journal of Medicine and Public Health, 74(7), 234.
Tan, T. Q., Bhattacharya, L., & Gerbie, M. V. (2010). Awareness, perceptions and knowledge of recommended adult vaccines among a nationwide sample of adult primary care providers. The Journal of Reproductive Medicine, 56(7–8), 301–307.
Kahn, J. A., Rosenthal, S. L., Tissot, A. M., Bernstein, D. I., Wetzel, C., & Zimet, G. D. (2007). Factors influencing pediatricians’ intention to recommend human papillomavirus vaccines. Ambulatory Pediatrics, 7(5), 367–373.
Young, J. L., Bernheim, R. G., Korte, J. E., Stoler, M. H., Guterbock, T. M., & Rice, L. W. (2011). Human papillomavirus vaccination recommendation may be linked to reimbursement: a survey of Virginia family practitioners and gynecologists. Journal of Pediatric and Adolescent Gynecology, 24(6), 380–385.
Freed, G. L., Cowan, A. E., Gregory, S., & Clark, S. J. (2008). Variation in provider vaccine purchase prices and payer reimbursement. Pediatrics, 122(6), 1325–1331.
Ruffin, M. T., Plegue, M. A., Rockwell, P. G., Young, A. P., Patel, D. A., & Yeazel, M. W. (2015). Impact of an electronic health record (EHR) reminder on human papillomavirus (HPV) vaccine initiation and timely completion. The Journal of the American Board of Family Medicine, 28(3), 324–333.
Humiston, S. G., & Rosenthal, S. L. (2005). Challenges to vaccinating adolescents: Vaccine implementation issues. The Pediatric Infectious Disease Journal, 24(6), S134–S140.
Szilagyi, P. G., Bordley, C., Vann, J. C., Chelminski, A., Kraus, R. M., Margolis, P. A., et al. (2000). Effect of patient reminder/recall interventions on immunization rates: A review. JAMA, 284(14), 1820–1827.
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009). Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics, 42(2), 377–381.
Healy, C. M., Montesinos, D. P., & Middleman, A. B. (2014). Parent and provider perspectives on immunization: Are providers overestimating parental concerns? Vaccine, 32(5), 579–584.
McRee, A., Gilkey, M. B., & Dempsey, A. F. (2014). HPV vaccine hesitancy: Findings from a statewide survey of health care providers. Journal of Pediatric Health Care, 28(6), 541–549.
Javanbakht, M., Stahlman, S., Walker, S., Gottlieb, S., Markowitz, L., Liddon, N., et al. (2012). Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community. Vaccine, 30(30), 4511–4516.
Gilkey, M. B., Moss, J. L., Coyne-Beasley, T., Hall, M. E., Shah, P. D., & Brewer, N. T. (2015). Physician communication about adolescent vaccination: How is human papillomavirus vaccine different? Preventive Medicine, 77, 181–185.
Leddy, M. A., Anderson, B. L., Gall, S., & Schulkin, J. (2009). Obstetrician-gynecologists and the HPV vaccine: practice patterns, beliefs, and knowledge. Journal of Pediatric and Adolescent Gynecology, 22(4), 239–246.
Ko, E. M., Missmer, S., & Johnson, N. R. (2010). Physician attitudes and practice toward human papillomavirus vaccination. Journal of lower genital tract disease, 14(4), 339–345.
Paul, P., & Fabio, A. (2014). Literature review of HPV vaccine delivery strategies: Considerations for school-and non-school based immunization program. Vaccine, 32(3), 320–326.
Brabin, L., Roberts, S. A., Stretch, R., Baxter, D., Chambers, G., Kitchener, H., et al. (2008). Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study. BMJ, 336(7652), 1056–1058.
Limia, A., & Pachón, I. (2011). Coverage of human papillomavirus vaccination during the first year of its introduction in Spain. Euro Surveill, 16(pii), 19873.
Perkins, R. B., & Clark, J. A. (2012). Providers’ attitudes toward human papillomavirus vaccination in young men challenges for implementation of 2011 recommendations. American Journal of Men’s Health, 6(4), 320–323.
Saraiya, M., Rosser, J. I., & Cooper, C. P. (2012). Cancers that US physicians believe the HPV vaccine prevents: Findings from a physician survey, 2009. Journal of Women’s Health, 21(2), 111–117.
Withy, K. (2015). Hawaii Physician Assessment Workforce Project. Retrieved January 2, 2016, from John A. Burns School of Medicine website: https://www.hawaii.edu/offices/eaur/govrel/reports/2015/act18-sslh2009_2015_physician-workforce_report.pdf.
Hawaii State Legislature. Retrieved January 1, 2016. http://www.capitol.hawaii.gov/Archives/measure_indiv_Archives.aspx?billtype=HB.
Acknowledgments
The authors gratefully acknowledge Noel T. Brewer, Ph.D. of the University of North Carolina Chapel Hill and Susan Vadaparampil, Ph.D, MPH of the Moffitt Cancer Center for their scientific discussions and Steve Hankins, MD, MPH and Youngju Jeong, MS of the John A. Burns School of Medicine, John Baleix MD, MPH, and Teresa Michaud for their technical contributions to the project.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors have no financial disclosures or conflicts of interest to report.
Funding Sources
This project is supported by the National Cancer Institute, Grant number 3 P30 CA071789-15S4.
Rights and permissions
About this article
Cite this article
Tom, A., Robinett, H., Buenconsejo-Lum, L. et al. Promoting and Providing HPV Vaccination in Hawaii: Barriers Faced by Health Providers. J Community Health 41, 1069–1077 (2016). https://doi.org/10.1007/s10900-016-0191-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10900-016-0191-9